Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, supports Advanced Accelerator Applications, a Novartis company, as a long-term supplier for the medical radioisotope component of the newly U.S. Food and Drug Administration (FDA) approved radiotherapeutic, Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treat
News | Prostate Cancer
ITM Provides n.c.a. Lutetium-177 as Long-Term Supplier for Recently Approved Novel Radiotherapeutic in Metastatic Prostate Cancer

March 28, 2022 — ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, supports ...

Time March 28, 2022
arrow
With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical therapy to treat metastatic castration-resistant prostate cancer (mCRPC)—the Society of Nuclear Medicine and Molecular Imaging (SNMMI) celebrates one of the greatest success stories in nuclear medicine history.
News | Prostate Cancer
SNMMI Applauds FDA Approval of New Metastatic Prostate Cancer Treatment

March 23, 2022 — With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical ...

Time March 23, 2022
arrow
F-18 FDG PET in COVID-19–related CNS disorders: Principal components analysis of spatial covariance pattern (first row) and statistical parametric mapping analysis of metabolic group differences (second to fifth rows) in patients with COVID-19–related encephalopathy, patients with post-COVID-19 syndrome, and patients with post-COVID-19 syndrome and hyposmia compared to healthy controls (n=13). Image Created by PT Meyer, S Hellwig, G Blazhenets and JA Hosp, Medical Center – University of Freiburg, Germany.
News | Coronavirus (COVID-19)
Molecular Imaging Uncovers Effects of COVID-19 on the Brain

March 23, 2022 — A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive ...

Time March 23, 2022
arrow
CMSU will bring its state-of-the-art AI medical devices to hospitals and local healthcare providers in a unique hands-on experience to create stronger community engagement throughout the year.
News | Digital Radiography (DR)
Canon Medical Systems USA Presents Its First-Ever U.S. Mobile Truck Tour with the Launch of Canon Across America

March 23, 2022 — Canon Medical Systems USA, Inc. (CMSU), a global leader in innovative diagnostic imaging technology, is ...

Time March 23, 2022
arrow
On March 17, NRG restarted the reactor in Petten, The Netherlands. At around 11 a.m., the capacity of 45 MW has been reached.
News | Nuclear Imaging
NRG High Flux Reactor Back in Full Operation

March 18, 2022 — On March 17, NRG restarted the reactor in Petten, The Netherlands. At around 11 a.m., the capacity of ...

Time March 18, 2022
arrow
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the Dana-Farber Brigham Cancer Center as its first two designated Radiopharmaceutical Therapy Centers of Excellence.
News | SNMMI
SNMMI designates first Radiopharmaceutical Therapy Centers of Excellence

March 16, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the ...

Time March 16, 2022
arrow
Convergent will use NorthStar’s Ac-225 to radiolabel its lead asset, CONV01-α, a prostate-specific membrane antigen (PSMA)-targeted monoclonal antibody, currently being investigated as a potential ground-breaking treatment for prostate cancer.
News | Prostate Cancer
NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

March 11, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time March 11, 2022
arrow
The American College of Radiology (#ACR) joins all Americans in calling for an immediate end to fighting in #Ukraine enabling medical providers to safely care for the sick and injured and humanitarian organizations to supply necessary aid. #UkraineUnderAttack
News | Nuclear Imaging
ACR Statement on Ukraine Invasion and Resulting Humanitarian Crisis

March 4, 2022 — The American College of Radiology (ACR) joins all Americans in calling for an immediate end to fighting ...

Time March 04, 2022
arrow
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) deplores the recent invasion of Ukraine that has resulted in the death and injury of a large number of innocent men, women, and children—a horrifying contrast to our work to save lives and improve patient care.
News | Nuclear Imaging
Position Statement from SNMMI Regarding Situation in Ukraine

March 3, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) deplores the recent invasion of Ukraine ...

Time March 03, 2022
arrow
The MARIA research reactor (Poland) has added additional operating days, which has helped to reduce the loss of HFR production capacity.
News | Nuclear Imaging
Update on HFR Reactor Outage – Medical Isotope Supply Returning to Normal

February 18, 2022 — The Nuclear Medicine Europe (NMEu) Emergency Response Team held a call on February 14 on the ...

Time February 18, 2022
arrow
18F-rhPSMA-7.3 PET Photo courtesy of Blue Earth Diagnostics. General use: This 18F-rhPSMA-7.3 PET image shows prostate cancer spread beyond the prostate region. Technical use: This 18F-rhPSMA-7.3 PET image shows detection of recurrent prostate cancer in several retroperitoneal lymph nodes, as indicated by the green arrows.
News | Prostate Cancer
Blue Earth Diagnostics Announces Key Results from Phase 3 SPOTLIGHT Study of 18F-rhPSMA-7.3

February 18, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time February 18, 2022
arrow
MURR staff work to produce lutetium-177 (Lu-177). Image courtesy of the University of Missouri
News | Nuclear Imaging
University of Missouri Research Reactor Helps Supply Critical Medical Isotopes During Global Disruption

February 11, 2022 — Due to a recent unexpected reactor shutdown in Europe, the University of Missouri Research Reactor ...

Time February 11, 2022
arrow
The Petten High Flux Reactor in Petten, Netherlands. Image by Tetzemann - Own work, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=83953498
News | Nuclear Imaging
Update on Unplanned Outage of the HFR Reactor

February 2, 2022 — Nuclear Medicine Europe has announced that the HFR reactor in Petten, Netherlands, did not resume ...

Time February 02, 2022
arrow
TeamBest Global Companies (TBG) and Best Cyclotron Systems, Inc. (BCS) announce the shipment of the world’s very first 6 MeV Proton Cyclotron, operating in excess of 500 micro amp current, to a National Lab today.
News | Molecular Imaging
Shipment of World’s Very First 6 MeV Proton Cyclotron

January 28, 2022 — TeamBest Global Companies (TBG) and Best Cyclotron Systems, Inc. (BCS) announce the shipment of the ...

Time January 28, 2022
arrow
On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that there will be a delay in the restart of the HFR Reactor that will impact the supply of Mo-99 and Lu-177 in coming weeks.
News | Nuclear Imaging
SNMMI Issues Alert That HFR Outage Will Impact Isotope Supply

January 26, 2022 — On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that ...

Time January 26, 2022
arrow
PET CT image of the Neck showing CA nasopharynx or carcinoma of nasopharynx from PET CT scannner.
News | PET Imaging
Clario and XingImaging Expand Partnership to Deliver PET Imaging Clinical Trials in China 

January 11, 2022 — Clario, a technology company that delivers the leading endpoint technology solutions for clinical ...

Time January 11, 2022
arrow
NNSA’s lease contract will provide SHINE with the low-enriched uranium necessary to produce Mo-99 while DOE-EM’s contract details requirements surrounding the return of any resulting radioactive waste unable to be disposed of commercially once Mo-99 production is complete.
News | Molecular Imaging
DOE Offices and SHINE Sign First-ever Contracts Under Uranium Lease and Take-back Program to Produce Domestic Mo-99

Janaury 10, 2022 — The Department of Energy’s National Nuclear Security Administration (NNSA) and Office of ...

Time January 10, 2022
arrow
Image from a co-registered PET-CT study from dual modality scanner. Patient with multiple metastatic lesions in liver & lung. PET data superimposed over CT scan axial slice through lung metastases
News | Molecular Imaging
Global Nuclear Imaging Market Report

December 29, 2021 — The global nuclear imaging devices and equipment market is expected to grow from $2.45 billion in ...

Time December 29, 2021
arrow
Figure courtesy of Nature Biomedical Engineering
News | Magnetic Resonance Imaging (MRI)
Magnetic Resonance Imaging and Artificial Intelligence Can Detect Early Signs of Tumor Cell Death After Novel Therapy

December 27, 2021 — In a recent study published in Nature Biomedical Engineering, a team led by researchers at ...

Time December 27, 2021
arrow
Carl Bjartmar
News | Molecular Imaging
Ascelia Pharma Presents Study Showing Comparable Efficacy of Orviglance Lesion Visualization and Detection to Gadolinium

December 7, 2021 — Orviglance* is a novel manganese-based oral contrast agent for magnetic resonance imaging (MRI) ...

Time December 07, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now